Curaleaf Announces Strong Preliminary Unaudited Fourth Quarter 2025 Results

Core Insights - Curaleaf Holdings, Inc. anticipates Q4 2025 net revenue to be at least $330 million, reflecting a sequential increase of approximately 4% and a year-over-year increase of 1% compared to Q4 2024 [1] - The company plans to discontinue its hemp business and exit Missouri due to new federal regulations, which combined contributed approximately $2 million in revenue in Q3 and Q4 2025 [1] - Adjusted gross profit margin for Q4 2025 is expected to be around 48.5%, consistent with Q4 2024, while the full year 2025 adjusted gross margin is projected to be approximately 50% [1] Financial Performance - Q4 2025 net revenue, excluding discontinued businesses, is expected to be at least $330 million, surpassing previous guidance of low single-digit growth [1] - The anticipated adjusted gross profit margin for Q4 2025 is approximately 48.5%, aligning with the previous year's margin [1] - Full year 2025 adjusted gross margin is expected to be around 50% [1] Strategic Decisions - The decision to discontinue the hemp division is a response to federal legislation that limits THC levels in hemp-derived products [1] - The exit from Missouri is based on the assessment that the company's presence in the state was not justifiable for continued investment [1] - The company aims to maintain a robust balance sheet while refinancing senior secured notes due in December 2026 [1]